165 related articles for article (PubMed ID: 34353426)
1. Acetate decreases PVR/CD155 expression via PI3K/AKT pathway in cancer cells.
Tran NL; Lee IK; Choi J; Kim SH; Oh SJ
BMB Rep; 2021 Aug; 54(8):431-436. PubMed ID: 34353426
[TBL] [Abstract][Full Text] [Related]
2. The immune checkpoint TIGIT/CD155 promotes the exhaustion of CD8 + T cells in TNBC through glucose metabolic reprogramming mediated by PI3K/AKT/mTOR signaling.
Huang M; Yu X; Wang Q; Jiang Z; Li X; Chen W; Song C
Cell Commun Signal; 2024 Jan; 22(1):35. PubMed ID: 38216949
[TBL] [Abstract][Full Text] [Related]
3. BCL9 regulates CD226 and CD96 checkpoints in CD8
Feng M; Wu Z; Zhou Y; Wei Z; Tian E; Mei S; Zhu Y; Liu C; He F; Li H; Xie C; Jin J; Dong J; Yang D; Yu K; Qian J; Lambrechts D; Wang MW; Zhu D
Signal Transduct Target Ther; 2021 Aug; 6(1):313. PubMed ID: 34417435
[TBL] [Abstract][Full Text] [Related]
4. Tumor intrinsic and extrinsic immune functions of CD155.
O'Donnell JS; Madore J; Li XY; Smyth MJ
Semin Cancer Biol; 2020 Oct; 65():189-196. PubMed ID: 31883911
[TBL] [Abstract][Full Text] [Related]
5. PI3K/Akt pathway involving into apoptosis and invasion in human colon cancer cells LoVo.
Jiang QG; Li TY; Liu DN; Zhang HT
Mol Biol Rep; 2014 May; 41(5):3359-67. PubMed ID: 24496855
[TBL] [Abstract][Full Text] [Related]
6. CD155 knockdown promotes apoptosis via AKT/Bcl-2/Bax in colon cancer cells.
Zheng Q; Wang B; Gao J; Xin N; Wang W; Song X; Shao Y; Zhao C
J Cell Mol Med; 2018 Jan; 22(1):131-140. PubMed ID: 28816021
[TBL] [Abstract][Full Text] [Related]
7. CD155T/TIGIT Signaling Regulates CD8
He W; Zhang H; Han F; Chen X; Lin R; Wang W; Qiu H; Zhuang Z; Liao Q; Zhang W; Cai Q; Cui Y; Jiang W; Wang H; Ke Z
Cancer Res; 2017 Nov; 77(22):6375-6388. PubMed ID: 28883004
[TBL] [Abstract][Full Text] [Related]
8. Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Lepletier A; Madore J; O'Donnell JS; Johnston RL; Li XY; McDonald E; Ahern E; Kuchel A; Eastgate M; Pearson SA; Mallardo D; Ascierto PA; Massi D; Merelli B; Mandala M; Wilmott JS; Menzies AM; Leduc C; Stagg J; Routy B; Long GV; Scolyer RA; Bald T; Waddell N; Dougall WC; Teng MWL; Smyth MJ
Clin Cancer Res; 2020 Jul; 26(14):3671-3681. PubMed ID: 32345648
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation.
Fionda C; Abruzzese MP; Zingoni A; Soriani A; Ricci B; Molfetta R; Paolini R; Santoni A; Cippitelli M
BMC Cancer; 2015 Jan; 15():17. PubMed ID: 25609078
[TBL] [Abstract][Full Text] [Related]
10. CD155 in tumor progression and targeted therapy.
Zhan M; Zhang Z; Zhao X; Zhang Y; Liu T; Lu L; Li XY
Cancer Lett; 2022 Oct; 545():215830. PubMed ID: 35870689
[TBL] [Abstract][Full Text] [Related]
11. The immune suppressive factors CD155 and PD-L1 show contrasting expression patterns and immune correlates in ovarian and other cancers.
Smazynski J; Hamilton PT; Thornton S; Milne K; Wouters MCA; Webb JR; Nelson BH
Gynecol Oncol; 2020 Jul; 158(1):167-177. PubMed ID: 32446718
[TBL] [Abstract][Full Text] [Related]
12. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer.
Qazi AK; Hussain A; Khan S; Aga MA; Behl A; Ali S; Singh SK; Taneja SC; Shah BA; Saxena AK; Mondhe DM; Hamid A
Cancer Lett; 2015 Apr; 359(1):47-56. PubMed ID: 25554016
[TBL] [Abstract][Full Text] [Related]
13. The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
Zhang L; Zhu S; Shi X; Sha W
Int J Clin Exp Pathol; 2015; 8(8):9097-104. PubMed ID: 26464652
[TBL] [Abstract][Full Text] [Related]
14. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of phospholipaseD2 increases hypoxia-induced human colon cancer cell apoptosis through inactivating of the PI3K/AKT signaling pathway.
Liu M; Fu Z; Wu X; Du K; Zhang S; Zeng L
Tumour Biol; 2016 May; 37(5):6155-68. PubMed ID: 26614430
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
17. CD155/PVR enhances glioma cell dispersal by regulating adhesion signaling and focal adhesion dynamics.
Sloan KE; Stewart JK; Treloar AF; Matthews RT; Jay DG
Cancer Res; 2005 Dec; 65(23):10930-7. PubMed ID: 16322240
[TBL] [Abstract][Full Text] [Related]
18. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
Lei Y; Wang YH; Wang XF; Bai J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
[TBL] [Abstract][Full Text] [Related]
19. CD155-Prognostic and Immunotherapeutic Implications Based on Multiple Analyses of Databases Across 33 Human Cancers.
Zhang H; Yang Z; Du G; Cao L; Tan B
Technol Cancer Res Treat; 2021; 20():1533033820980088. PubMed ID: 33576304
[TBL] [Abstract][Full Text] [Related]
20. CD155/TIGIT, a novel immune checkpoint in human cancers (Review).
Liu L; You X; Han S; Sun Y; Zhang J; Zhang Y
Oncol Rep; 2021 Mar; 45(3):835-845. PubMed ID: 33469677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
